Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab

Age-related macular degeneration (AMD) is a leading cause of blindness in the modern world. The standard treatment regimen for neovascular AMD is the monthly/bimonthly intravitreal injection of anti-VEGF agents such as ranibizumab or aflibercept. However, these repeated invasive injections can lead...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Rini Rachel, Tan, Dulcia Wei Ni, Ramon, Moreno Raja Miguel, Natarajan, Jayaganesh V., Agrawal, Rupesh, Wong, Tina T, Venkatraman, Subbu S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711922/
https://www.ncbi.nlm.nih.gov/pubmed/29196745
http://dx.doi.org/10.1038/s41598-017-16791-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711922/
https://www.ncbi.nlm.nih.gov/pubmed/29196745
http://dx.doi.org/10.1038/s41598-017-16791-7

Ejemplares similares